Latest News and Press Releases
Want to stay updated on the latest news?
-
Office of the CEO Established to Oversee Business Operations Board Forms Transition Committee and Commences CEO Search NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq:...
-
Denali plans to continue clinical development of DNL593, which is designed to deliver progranulin to the brain using TransportVehicle™ technologyResults from ongoing Phase 1/2 study in patients with...
-
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP informs investors that a securities fraud class action lawsuit has been filed against Aldeyra Therapeutics,...
-
LOS ANGELES, April 03, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming April 13, 2026 deadline to file a lead plaintiff motion in the class action...
-
New class action for Driven Brands (DRVN) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 5/8/2026.
-
HAMILTON, N.J., April 03, 2026 (GLOBE NEWSWIRE) -- First Bank (Nasdaq Global Market: FRBA) invites participation in a conference call to discuss the Company’s financial and operating performance...
-
VITL Investors Have Opportunity to Lead Vital Farms, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
Vilkyškių pieninė AB (hereinafter referred to as the Company), company code 277160980, by the initiative and decision of the Board, convenes the Ordinary General Meeting of Shareholders on 27 April...
-
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
COTY Investors Have Opportunity to Lead Coty Inc. Securities Fraud Lawsuit with the Schall Law Firm